Abstract
The Italian national health system funds universal health care through general taxation, but health services are provided by local institutions. This study examines the epidemiology, provision, and funding of renal replacement therapy (RRT) in Italy. In 2001, prevalence and incidence of RRT in Italy were 0.083% and 0.014%, respectively. A 1999 donation law markedly increased renal transplantation rates. Italy spends 8.3% of its GDP on health care; 1.8% is for end-stage renal disease (ESRD) patients, who represent 0.083% of the general population. The reorganization of the NHS requires attention from the health community so that economic and geographic health disparities are not exacerbated.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ciancio, B. C., Venettoni, S., Mattucci, D. A., & Nanni Costa, A. (2005). Il trapianto di rene in Italia una realtà in evoluzione. Giornale Italiano di Nefrologia, 21(Suppl 31), S26–9.
Conte F. (2004). Registro Italiano di Dialisi e Trapianto. Esperienza 1996–2001. Giornale Italiano di Nefrologia 6: 561–567
Conte F., Salomone M., Baracca A., Di Giulio S., Locatelli F., Piccoli G., Santoro A., Zoccali C., Colasanti G. (1998). Registro Italiano Dialisi e Trapianto (First Report). Giornale Italiano di Nefrologia 15: 271–9
Dor, A., Pauly, M. V., Eichleay, M. A., & Held, P. J. (2007). End-stage renal disease and economic incentives: The International Study of Health Care Organization and Financing (ISHCOF). International Journal of Health Care Finance and Economics. DOI: 10.1007/s10754-007-9024-9
De Negri A., Formica M., Cavagnino A. (1997) Valutazione dei costi dei trattamenti dialitici. Giornale Italiano di Nefrologia 14: 325–9
ERA-EDTA. (2003). Annual report 2003. Amsterdam: European Renal Association. Retrieved June 2005, at http://www.era-edta-reg.org.
Eurostat. GDP per Capita in PPS. Luxembourg: Eurostat. Retrieved June, 2005, at http://epp.eurostat.cec.eu.int/portal/page?_pageid=1090,30070682,1090_33076576&_dad=portal&_schema= PORTAL.
Fuiano G., Zoccali C. (2003a) Linee guida per il trattamento dell’anemia nell’insufficienza renale cronica. Giornale Italiano di Nefrologia 20(Suppl 24): S61-S82
Fuiano G., Zoccali C. (2003b) Linee guida osteodistrofia renale. Giornale Italiano di Nefrologia 20(Suppl 24): S83-S95
Hecking, E., Bragg-Gresham, J. L., Rayner, H. G., Pisoni, R. L., Andreucci, V. E., Combe, C., Greenwood, R., McCullough, K., Feldman, H. I., Young, E. W., Held, P. J., & Port, F. K. (2004). Haemodialysis prescription, adherence and nutritional indicators in five European countries: Results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrology Dialysis and Transplantation, 19, 100–7.
Horl W.H., De Alvaro F., Williams P.F. (1999) Healthcare systems and end-stage renal disease (ESRD) therapies – an international review: Access to ESRD treatment. Nephrology Dialysis and Transplantation 14(Suppl 6): S10-S15
Lameire N., Joffe P., Wiedemann M. (1999) Healthcare systems – an international review: An overview. Nephrology Dialysis and Transplantation 14(Suppl 6): S3-S9
Lee H., Manns B.J., Taub K., Ghali W., Dean S., Johnson D., Donaldson C. (2002) Cost analysis of ongoing care of patients with end-stage renal disease: The impact of dialysis modality and dialysis access. American Journal of Kidney Diseases 40: 611–622
Locatelli F., Marcelli D., Conte F. (1995) 1983 to 1992: Report on regular dialysis and transplantation in Lombardy. American Journal Kidney Diseases 25: 196–205
Locatelli F., Del Vecchio L. (1999) How long can dialysis be postponed by low protein diet and ACE inhibitors?. Nephrology Dialysis and Transplantation 14: 1360–1364
Locatelli F., Marcelli D., Conte F., D’Amico M., Del Vecchio L., Limido A., Malberti F., Spotti D. (2000a) Cardiovascular disease in chronic renal failure: the challenge continues. Nephrology Dialysis Transplantation 15(Suppl 5): 69–80
Locatelli F., Pontoriero G., Del Vecchio L., Conte F. (2000b) Technical-economic management models in dialytic treatment: an evolving reality: The Italian experience. Journal of Nephrology 13(suppl 3): S20-S27
Locatelli F., Tentori F., Del Vecchio L., Pontoriero G. (2004) Application of dialysis and transplant registries to clinical practice: The Lombardy Registry. Nephrology Dialysis and Transplantation 19(Suppl 3): iii2-iii4
Manno C., Schena F.P. (1996) Il sistema dei DRG in nefrologia. In: Enia G., Zoccali C. (eds). Seminari di nefrologia. Wichiting Editore, Milano, pp. 75–86
Ministero della Salute, Centro Nazionale Trapianti. Attività donazione e trapianto 2004 – dati al 31 dicembre 2004. Retrieved April 3, 2007, at http://www.ministerosalute.it/cnt/cntStatistiche.jsp?area=cnt-generale&menu=menuPrincipale&label=datdoc&titolo=1111&etichetta=
Nissenson A.R., Prichard S.S., Cheng I.K.P., Gokal R., Kubota M., Maiorca R., Riella M.C., Rottembourg J. (1993) Non-medical factors that impact on ESDR modality selection. Kidney International 43(Suppl 40): S120–S127
OECD. (2004). OECD health data 2004. Paris: Organization for Economic Cooperation and Development. CD Rom.
OECD. (2005). OECD heath data 2005: How does Italy compare. Paris: Organization for Economic Cooperation and Development. Retrieved February, 2007, at http://www.oecd.org/dataoecd/16/5/34970099.pdf
OECD. (2006). Purchasing power parities (PPPs) for OECD countries 1980–2005. Paris: Organization for Economic Cooperation and Development. Retrieved February, 2007, at http://www.oecd.org/statisticsdata/ 0,2643,en_2649_34357_1_119656_1_1_1,00.html
Postorino, M., Salomone, M., & Rosati, A. (2005). Registro Italiano di Dialisi e Trapianto: Report preliminare, 2003. Montesilvano (PE), Italy: Società Italiana di Nefrologia. Retrieved June, 2005, at http://www.sin-ridt.org/sin-ridt/sin-ridt.org.htm.
Pisoni R.L., Gillespie B.W., Dickinson D.M., Chen K., Kutner M., Wolfe R.A. (2004) The Dialysis Outcomes and Practice Patterns Study: Design, data elements, and methodology. American Journal of Kidney Diseases 44(Suppl 2): S7–S15
Pozzi C., Bolasco P., Fogazzi G., Andrulli S., Altieri P., Ponticelli C., Locatelli F. (1999) Corticosteroids in IgA nephropathy: A randomised controlled trial. Lancet 353: 883–887
Rayner H.C., Pisoni L.R., Bommer J., Canaud B., Hecking E., Locatelli F., Piera L., Bragg-Gresham J.L., Feldman H.I., Goodkin D.A., Gillespie B., Wolfe R.A., Held P.J., Port F.K. (2004) Mortality and hospitalization in haemodialysis patients in five European countries: Results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrology Dialysis Transplantation 19: 108–120
Saran R., Bragg-Gresham J.L., Wizemann V., Twardowski Z., Saito A., Levin N.W., Kimata N., Gillespie B.W., Combe C., Bommer J., Akiba T., Young E.W., Port F.K. (2006) Longer treatment time and slower ultrafiltration in hemodialysis: Associations with reduced mortality in the DOPPS. Kidney International 69: 1222–1228
Venettoni S., Scalamogna M., Curtoni E.S., Adorno D., Marino I.R., Taioli E., Ciancio B.C., Rizzato L., Costa A.N. (2004) Transplant quality in Italy: Analysis of the 1995–200 period. Transplant International 17(8): 402–415
WHO. (2000). The world health report 2000 – Health systems: improving performance. Geneva: World Health Organization.
Young E.W., Goodkin D.A., Mapes D.L., Port F.K., Keen M.L., Chen K., Maroni B.L., Wolfe R.A., Held P.J. (2000) The Dialysis Outcomes and Practice Patterns Study: An international hemodialysis study. Kidney International 57(Suppl 74): S74–S81
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pontoriero, G., Pozzoni, P., Vecchio, L.D. et al. International Study of Health Care Organization and Financing for renal replacement therapy in Italy: an evolving reality. Int J Health Care Finance Econ 7, 201–215 (2007). https://doi.org/10.1007/s10754-007-9016-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10754-007-9016-9